All In Biotech

Drug Trial Radar · NCT02495324

Fimasartan Achieving SBP Target (FAST) Study

A Randomized, Double-blind, Active Control, 3-parallel Group, Forced Titration, Multicenter, Phase IV Study to Evaluate the Efficacy and Safety of Fimasartan Versus Valsartan Monotherapy in Patients With Mild to Moderate Essential Hypertension

Last checked: Nov 19, 2026Latest source record: Jul 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 369 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

369

Actual

Start

Jun 2015

Primary completion

May 2017

Study completion May 2017

Sponsor

Sponsor type
Industry
First posted
Jul 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 19 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of Fimasartan compared to Valsartan and Olmesartan(reference group) in patients with mild to moderate essential hypertension. Patients have 2 weeks of placebo run-in and wash out period, 2 weeks of taking required dose and 4 weeks of taking double dose.

Conditions

  • Essential,Hypertension

Interventions

  • PlaceboDrug

    2 weeks of placebo PO daily

  • FimasartanDrug

    60mg 1 tab PO daily for 2 weeks and 120mg 1 tab PO daily for 4 weeks

  • ValsartanDrug

    80mg 1 tab PO daily for 2 weeks and 160mg 1 tab PO daily for 4 weeks

  • Olmesartan medoxomilDrug

    10mg 1 tab PO daily for 2 weeks and 20mg 1 tab PO daily for 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of sitting SBP from baseline after taking investigational products for 6 weeks.Time frame: 6 weeks from baseline visit

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • The Catholic University of Korea, Seoul St.Mary's Hospital

    Seoul, Banpo-dong, Seocho-gu, South Korea

  • The Catholic University of Korea, Incheon St.Mary's Hospital

    Incheon, Bupyeong-gu, South Korea

  • The Catholic University of Korea, St. Paul's Hospital

    Seoul, Dongdaemun-gu, South Korea

  • The Catholic University of Korea, Bucheon St.Mary's Hospital

    Bucheon-si, Gyeonggi-do, South Korea

  • The Catholic University of Korea, St.Vincent's Hospital.

    Suwon, Gyeonggi-do, South Korea

  • The Catholic University of Korea,Uijeongbu St.Mary's Hospital

    Uijeongbu-si, Gyeonggi-do, South Korea

  • The Catholic University of Korea, Daejeon St. Mary's Hospital

    Daejeon, Jung-gu/Daeheung-ro, South Korea

  • The Catholic University of Korea,Yeouido St.Mary's Hospital

    Seoul, Yeongdeungpo-gu, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.